Insights On Partnering

31. 2025 Clinical Trial Payment Tax Implications Explained 10/8/2025

    Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.

32. Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments 10/30/2024

    Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.

33. 6 Steps To Help You Choose The Right Clinical Trial Partner 9/12/2025

    The right digital partner can unlock speed, scale, and collaboration that can transform the future of your pipeline. Learn the six steps to help you choose the right partner for your trials.

34. Accelerating Trial Start-Up: CRO Best Practices For 2025 7/8/2025

    In 2025, accelerating clinical trial start-up is critical, and Clinical Research Organizations (CROs) are applying innovative approaches to drive efficiency in site activation, enrollment, and regulatory approvals.

35. Analyzing 1,000+ Study Startup Records For Recruitment Performance 5/17/2024

    This overview highlights real research programs at various stages of the recruitment process and demonstrates the impact of Advarra’s Longboat Platform across multiple therapeutic areas and sponsors.

36. Elevating The Site Voice 3/27/2025

    A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

37. Are You An Emerging Biotech? Things To Consider When Selecting A CRO 7/22/2024

    Better understand how smaller biotech companies should approach CRO selection and what they should consider before launching their clinical development program.

38. The Rise Of The Site: Empowering Efficient Clinical Study Execution 2/18/2025

    Join the Co-CEO of CRIO, as he explores research site challenges and how site-based technologies can reduce administrative burdens, enhance efficiency, and eliminate redundant one-time-use technologies.

39. Development And Manufacture Of A Highly Potent OSD Product 10/20/2025

    Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.

40. The High Cost Of CRO Turnover (And How You Can Avoid It) 9/18/2024

    Though some turnover is an inevitable part of a business’s life cycle, there are several strategies available to ensure a consistent CRO team throughout the span of your trial.